Knowledge, attitude, intention, and religion aspect toward fertility preservation among obstetrics and gynecology residents in Indonesia: A cross-sectional study


Background: The lack of knowledge from healthcare providers regarding fertility preservation will certainly affect the patient’s knowledge, attitude, behavior, and also perspective. Obstetrics and Gynecology (OB/GYN) residents may most likely be the first line professionals to integrate fertility preservation technologies into their practice which plays an important task in giving an understanding of the relationship between age and fertility for patients.

Objective: This study aims to assess OB/GYN resident knowledge and beliefs regarding age-related fertility decline, intentions, and religion aspect toward fertility preservation.

Materials and Methods: A cross-sectional study was conducted on 92 Indonesian OB/GYN residents at the Cipto Mangunkusomo Hospital between November and December 2017. Data were collected using a questionnaire which had four sections, knowledge, attitude, intention, and religion aspect toward fertility preservation.

Results: The majority of participants believed that an OB/GYN should encourage discussions about potential childbearing desires (96.74%) and age-related fertility decline (94.57%) with patients, of which 79.34% believed that these discussions should be part of a woman’s annual health examination. Cancer patients are likely to undergo oocyte cryopreservation than people who choose career as priority. From the religion aspect, fertility preservation options such as sperm, oocyte, embryo, and ovarian cortex cryopreservation were accepted by most residents with varied religions, while oocyte and sperm donor methods were unacceptable (48% and 57%, respectively) because of the belief that oocyte/sperm should only be given to legitimate partners, but many still do not know that oocyte and sperm donor were prohibited by all religions.

Conclusion: Age-related fertility decline and frozen egg storage should be discussed during annual woman wellness examinations by OB/GYN specialists.

Key words: Knowledge, Attitude, Intention, Fertility preservation.

[1] Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: 359–386.

[2] Tjindarbumi D, Mangunkusumo R. Cancer in Indonesia, present and future. Jpn J Clin Oncol 2002; 32 (Suppl.): S17–S21.

[3] Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001; 7: 535–543.

[4] Momen NC, Ernst A, Arendt LH, Olsen J, Li J, Gissler M, et al. Maternal cancer and congenital anomalies in children-a Danish nationwide cohort study. PLOS ONE 2017; 12: e0173355.

[5] Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31: 2500–2510.

[6] Adams E, Hill E, Watson E. Fertility preservation in cancer survivors: a national survey of oncologists’ current knowledge, practice and attitudes. Br J Cancer 2013; 108: 1602–1615.

[7] ESHRE Task Force on Ethics and Law, Dondorp W, de Wert G, Pennings G, Shenfield F, Devroey P, et al. Oocyte cryopreservation for age-related fertility loss. Hum Reprod 2012; 27: 1231–1237.

[8] Chehin MB, Bonetti TC, Serafini PC, Motta E. Knowledge regarding fertility preservation in cancer patients: a population-based survey among Brazilian people during the Pink October awareness event. JBRA Assist Reprod 2017; 21: 84–88.

[9] Yu L, Peterson B, Inhorn MC, Boehm JK, Patrizio P. Knowledge, attitudes, and intentions toward fertility awareness and oocyte cryopreservation among obstetrics and gynecology resident physicians. Hum Reprod 2016; 31: 403–411.

[10] Bunting L, Tsibulsky I, Boivin J. Fertility knowledge and beliefs about fertility treatment: findings from the International fertility decision-making study. Hum Reprod 2013; 28: 385–397.

[11] Dunson DB, Colombo B, Baird DD. Changes with age in the level and duration of fertility in the menstrual cycle. Hum Reprod 2002; 17: 1399–1403.

[12] Williamson LE, Lawson KL, Downe PJ, Pierson RA. Informed reproductive decision-making: the impact of providing fertility information on fertility knowledge and intentions to delay childbearing. J Obstet Gynaecol Can 2014; 36: 400–405.

[13] Wyndham N, Figueira PG, Patrizio P. A persistent misperception: assisted reproductive technology can reverse the “aged biological clock”. Fertil Steril 2012; 97: 1044–1047.

[14] Aflatoonian A, Eftekhar M, Mohammadian F, Yousefnejad F. Outcome of assisted reproductive technology in women aged 40 years and older. Iran J Reprod Med 2011; 9: 281–284.

[15] Hodes-Wertz B, Druckenmiller S, Smith M, Noyes N. What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility? Fertil Steril 2013; 100: 1343–1349.

[16] Mesen TB, Mersereau JE, Kane JB, Steiner AZ. Optimal timing for elective egg freezing. Fertil Steril 2015; 103: 1551–1556.

[17] Buske D, Sender A, Richter D, Brähler E, Geue K. Patientphysician communication and knowledge regarding fertility issues from german oncologists’ perspective-a quantitative survey. J Cancer Educ 2016; 31: 115–122.

[18] Shimizu C, Bando H, Kato T, Mizota Y, Yamamoto S, Fujiwara Y. Physicians’ knowledge, attitude, and behavior regarding fertility issues for young breast cancer patients: a national survey for breast care specialists. Breast Cancer 2013; 20: 230–240.

[19] Serour GI. Islamic perspectives in human reproduction. Reprod Biomed Online 2008; 17: 34–38.

[20] Al-Bar MA, Chamsi-Pasha H. Assisted reproductive technology: Islamic perspective. Contemporary bioethics: Islamic perspective. Switzerland: Spinger; 2015: 173–186.

[21] Schenker JG. Women’s reproductive health: monotheistic religious perspectives. Int J Gynecol Obstet 2000; 70: 77–86.

[22] Lauritzen P. Technology and wholeness: oncofertility and catholic tradition. Cancer Treat Res 2010; 156: 295–306.

[23] Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril 2013; 99: 37–43.

[24] Indonesia PPR. Peraturan Pemerintah Republik Indonesia No. 61 Tahun 2014 Tentang Kesehatan reproduksi; 24–49. Available from

[25] Kim SS. Fertility preservation in female cancer patients: current developments and future directions. Fertil Steril 2006; 85: 1–11.

[26] Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer: A pilot survey of survivors’ attitudes and experiences. Cancer 1999; 86: 697–709.

[27] Carter J, Rowland K, Chi D, Brown C, Abu-Rustum N, Castiel M, et al. Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecol Oncol 2005; 97: 90–95.

[28] Tsafrir A, Haimov-Kochman R, Margalioth EJ, Eldar-Geva T, Gal M, Bdolah Y, et al. Ovarian stimulation for oocyte cryopreservation for prevention of age-related fertility loss: one in five is a low responder. Gynecol Endocrinol 2015; 31: 779–782.

[29] Peterson BD, Pirritano M, Block JM, Schmidt L. Marital benefit and coping strategies in men and women undergoing unsuccessful fertility treatments over a 5-year period. Fertil Steril 2011; 95: 1759–1763.

[30] Holton S, Rowe H, Fisher J. Women’s health and their childbearing expectations and outcomes: a population-based survey from Victoria, Australia. Women’s Health Issues 2011; 21: 366–373.

[31] Azhar E, Seifer DB, Melzer K, Ahmed A, Weedon J, Minkoff H. Knowledge of ovarian reserve and reproductive choices. J Assist Reprod Genet 2015; 32: 409–415.